Toshihide Shishido
Papers
2
Total Citations
16
H-Index
2
About
Dr. Toshihide Shishido is a leading urologic oncologist whose research focuses on refining risk stratification and prognostic tools for prostate cancer. His major contributions center on the clinical significance of histopathological patterns, particularly the cribriform morphology in Gleason score 4+4 disease. In his highly cited 2024 study, Dr. Shishido demonstrated that the ratio of cribriform pattern area is a critical predictor of biochemical recurrence (BCR) following robot-assisted radical prostatectomy, offering surgeons a more precise metric for postoperative management. This work, accumulating 11 citations, directly addresses the need to move beyond traditional Gleason grading by quantifying tumor architecture. Additionally, his 2022 development of a prostate-specific antigen (PSA) nomogram, enhanced by area under the receiver operating characteristic curve (AUC) boosting, provides a novel, data-driven method to predict advanced prostate cancer. With 5 citations, this tool improves upon conventional PSA-based screening by integrating machine learning to boost diagnostic accuracy. Dr. Shishido’s research bridges pathology and computational modeling, empowering clinicians to tailor treatment decisions and better identify high-risk patients. His work is essential reading for urologists and pathologists seeking to advance precision oncology in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2